JPH07124154A - Contact medium for probe of ultrasonic diagnostic device - Google Patents
Contact medium for probe of ultrasonic diagnostic deviceInfo
- Publication number
- JPH07124154A JPH07124154A JP1804793A JP1804793A JPH07124154A JP H07124154 A JPH07124154 A JP H07124154A JP 1804793 A JP1804793 A JP 1804793A JP 1804793 A JP1804793 A JP 1804793A JP H07124154 A JPH07124154 A JP H07124154A
- Authority
- JP
- Japan
- Prior art keywords
- gel
- curdlan
- contact medium
- probe
- heating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims abstract description 32
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 45
- 229920002558 Curdlan Polymers 0.000 claims abstract description 41
- 239000001879 Curdlan Substances 0.000 claims abstract description 41
- 235000019316 curdlan Nutrition 0.000 claims abstract description 41
- 229940078035 curdlan Drugs 0.000 claims abstract description 41
- 238000010438 heat treatment Methods 0.000 abstract description 23
- 230000001954 sterilising effect Effects 0.000 abstract description 11
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 10
- 229920001282 polysaccharide Polymers 0.000 abstract description 5
- 239000005017 polysaccharide Substances 0.000 abstract description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 2
- 238000003303 reheating Methods 0.000 abstract description 2
- 235000000346 sugar Nutrition 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- 239000000499 gel Substances 0.000 description 54
- 239000002609 medium Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000006185 dispersion Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 9
- 238000001879 gelation Methods 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000005336 cracking Methods 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920002305 Schizophyllan Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229920002984 Paramylon Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- -1 etc.) Chemical compound 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 229920000592 inorganic polymer Polymers 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 238000009931 pascalization Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000010882 preoperative diagnosis Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229920000247 superabsorbent polymer Polymers 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は超音波診断装置の探触子
(プローブ)用接触媒体に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a contact medium for a probe of an ultrasonic diagnostic apparatus.
【0002】[0002]
【従来の技術】近年、内臓器疾患の治療においては、患
者の体力的負担を軽減し、予後の経過を良好にせしめる
ために、大がかりな外科手術を行うことなく治療する方
法が多数試みられている。また、仮に開腹手術を行うと
しても、術前に病巣部の様子を詳細に知ること、並びに
術中に臓器表面を切開することなく内部の様子を知るこ
とは、実際の手術の際に極めて有意義な情報をもたらす
ことになる。本目的を達成するために、超音波診断が近
年著しく発展普及し、これを用いた術前診断の正確さ
は、最近の手術成績の向上に大いに役立っている。特に
甲状腺疾患に超音波診断法と穿刺吸引細胞診を組み合わ
せることにより診断能の飛躍的向上がなされた。2. Description of the Related Art In recent years, in the treatment of internal organ diseases, many methods have been tried in order to reduce the physical burden on the patient and to improve the prognosis, without the need for major surgery. There is. Even if a laparotomy is performed, it is extremely meaningful to know the state of the lesion before the operation and to know the internal state of the organ without cutting the surface of the organ during the operation. It will bring information. In order to achieve this purpose, ultrasonic diagnosis has been remarkably developed and spread in recent years, and the accuracy of preoperative diagnosis using it has greatly contributed to the improvement of recent surgical results. Especially, by combining ultrasonic diagnosis and fine needle aspiration cytology with thyroid disease, the diagnostic ability has been dramatically improved.
【0003】しかしながら、体表面もしくは臓器表面に
直接超音波診断装置のプローブを当てて内部の状態を観
察しようとした際に超音波診断装置の特性上、表面下数
cm以内の領域での鮮明な画像を得ることは非常に困難で
ある。また、実際の体・臓器表面は平らな状態ではな
く、各々に特徴的な湾曲・凹凸を持つことになるため、
ある一定の形態を保った不可変なプローブでは目的の部
位に密着させることは不可能である。すなわち、生体と
プローブの間に空気が介在すると超音波伝播率の著しい
低下が起こり、診断装置上に正確な画像を結ばなくな
る。However, when the probe of the ultrasonic diagnostic apparatus is directly applied to the body surface or the surface of the organ to observe the internal state, due to the characteristics of the ultrasonic diagnostic apparatus, the subsurface number
It is very difficult to get a clear image in the area within cm. In addition, the actual surface of the body / organ is not in a flat state, but each has its own characteristic curves and irregularities,
It is impossible to adhere to a target site with an immutable probe that maintains a certain shape. That is, if air is present between the living body and the probe, the ultrasonic wave transmissivity is significantly reduced, and an accurate image cannot be formed on the diagnostic device.
【0004】かかる上記の問題を解決するため、プロー
ブと生体との間に適当なスペーサー(接触媒体)を介在
せしめることが有効である。接触媒体はシート状にして
診断の際にプローブと体表面等との間に挟むか、あるい
は適当な形状に成形しプローブに直接または治具で装着
して使用できるものが好ましい。このような接触媒体に
は適当な柔軟性と機械的強度及び良好な音響特性(超音
波減衰率が低いこと等)を有することが要求され、例え
ば、特開昭55-63636には特定の含水高分子ゲルが開示さ
れている。しかしながら、ここで開示されているゲルは
機械的強度が不十分であったり音波の減衰が大きいなど
の問題を有しており、その後、これらを改善すべくさま
ざまな努力がなされている。例えば、ポリビニルアルコ
ール系高分子ゲル(特開昭 62-298342、特公平 2-4621
1)、高吸水性樹脂(特開平 4-53544)、各種有機・無
機高分子(特公平 2-2152)のものが知られている。In order to solve the above problems, it is effective to interpose an appropriate spacer (contact medium) between the probe and the living body. The contact medium is preferably in the form of a sheet, which is sandwiched between the probe and the body surface or the like at the time of diagnosis, or formed into an appropriate shape and can be used by being attached to the probe directly or by a jig. Such a contact medium is required to have appropriate flexibility, mechanical strength, and good acoustic characteristics (low ultrasonic attenuation rate, etc.). For example, Japanese Patent Laid-Open No. 55-63636 discloses Polymer gels are disclosed. However, the gels disclosed here have problems such as insufficient mechanical strength and large attenuation of sound waves, and various efforts have been made since then to improve them. For example, polyvinyl alcohol type polymer gel (Japanese Patent Laid-Open No. 62-298342, Japanese Patent Publication No. 2-4621).
1), super absorbent polymer (JP-A-4-53544) and various organic and inorganic polymers (Japanese Patent Publication No. 2152) are known.
【0005】[0005]
【発明が解決しようとする課題】しかしながら、上記の
ような高分子ゲルは依然として種々の問題を有してい
た。すなわち、合成高分子を用いたものは、穿刺時ある
いは術中にゲルの一部もしくはゲル自体が生体内に混入
・留置される可能性があり、ゲルそのものや残留モノマ
ーに由来する毒性が懸念され、安全性の上で問題があっ
た。また、安全性が高いと考えられる天然高分子やポリ
ビニルアルコールゲルも音響特性が不十分であり(例え
ば減衰率が高い)、この様な音響特性を向上させるに
は、含水率を上げる必要があり、一方、含水率をあげる
と機械的強度が低下してしまうという欠点があった。ま
たポリビニルアルコールゲルは圧力を加えると離水し易
く、体・臓器表面に押し付けて使用するプローブ用接触
媒体としては不向きであった。加えて滅菌性に劣る(簡
便な滅菌法であるオートクレーブによる121℃の加熱
で完全に溶解し、原形をとどめ得ない)ため実用化に至
っていない。このような状況から、従来より穿刺・術中
にも使用可能で安全なプローブ用接触媒体が望まれてい
た。However, the polymer gel as described above still has various problems. That is, when using a synthetic polymer, there is a possibility that part of the gel or the gel itself may be mixed and left in the body during puncture or during surgery, and there is concern about the toxicity derived from the gel itself and residual monomers. There was a safety issue. Also, natural polymers and polyvinyl alcohol gels, which are considered to have high safety, have insufficient acoustic characteristics (for example, high attenuation rate), and it is necessary to increase the water content in order to improve such acoustic characteristics. On the other hand, there is a drawback that the mechanical strength is lowered when the water content is increased. Further, polyvinyl alcohol gel easily releases water when pressure is applied, and is not suitable as a contact medium for a probe that is pressed against the surface of a body or an organ for use. In addition, it has poor sterility (it cannot be put into practical use because it cannot be retained in its original form because it is completely dissolved by heating at 121 ° C. in an autoclave, which is a simple sterilization method). Under such circumstances, there has been a demand for a safe contact medium for a probe that can be used during puncture and surgery.
【0006】[0006]
【課題を解決するための手段】そこで本発明者等は、上
記課題を解決するため鋭意研究を行った結果、天然多糖
類であるカードランを主成分とするゲルを高圧処理して
プローブ用接触媒体として用いることにより、これらの
問題が全て解決されることを見いだし、本発明を完成し
た。カードランより調製したゲルは、安全性が極めて高
く、仮に体内に留置されても長時間かけて生体内で徐々
に分解される性質を有する(薬学雑誌 110 (10) 869-87
5, 1990 )。しかしながら、高度に精製されたカードラ
ンから得られるゲルは121℃、20分間のオートクレ
ーブ滅菌でひび割れを生じるなど、耐熱性の点ではまだ
十分に満足できるものではなかった。しかし、本発明者
らはゲル化に引き続いて高圧処理を施すことによって、
カードランゲルの加熱耐性を向上させ得ることを見いだ
し、この問題を解決したのである。すなわち高圧処理カ
ードランゲルは、簡便な滅菌装置オートクレーブで加熱
滅菌が可能であり、超音波診断装置用プローブの接触媒
体、特に穿刺・術中に使用するプローブの接触媒体とし
て極めて優れている。以下、本発明の構成について詳述
する。The inventors of the present invention have conducted diligent research to solve the above-mentioned problems, and as a result, have conducted a high-pressure treatment on a gel containing curdlan, which is a natural polysaccharide, as a main component to bring it into contact with a probe. We have found that all these problems can be solved by using it as a medium, and completed the present invention. Gels prepared from curdlan are extremely safe and have the property of gradually degrading in vivo over a long period of time even if they are left in the body (Pharmaceutical Journal 110 (10) 869-87).
5, 1990). However, the gel obtained from highly purified curdlan is still not sufficiently satisfactory in terms of heat resistance, such as cracking when autoclaved at 121 ° C. for 20 minutes. However, the present inventors have found that by subjecting the gelation to a high pressure treatment,
They found that the heating resistance of curdlan gel could be improved and solved this problem. That is, the high-pressure treated curdlan gel can be heat sterilized by a simple sterilizer autoclave, and is extremely excellent as a contact medium for a probe for an ultrasonic diagnostic apparatus, particularly for a probe used during puncture or surgery. Hereinafter, the configuration of the present invention will be described in detail.
【0007】[0007]
【構成の具体的な説明】本プローブ用接触媒体はカード
ランを主成分とする高含水ゲルである。カードランにつ
いては、日本食品工業学会誌Vol.38,No.8,736-742(199
1) などに記載されており、微生物(Alcaligenes faeca
lis var.myxogenesまたはAgrobacteriumの多くの菌株や
Rizobium)が産生する多糖類の一種で、構成糖はD-グル
コースのみであり、そのグルコシド結合の99%以上が
β-1,3結合である。カードランは水に不溶であるが、水
酸化ナトリウムなどのアルカリ性水溶液には溶解する。
カードランの均一な水分散液の調製法としては、カード
ラン粉末に水を加え高速ホモジナイザーもしくはカッタ
ーミキサー等で激しく撹拌するか、55℃程度の温水に
手やプロペラ撹拌機等を用いて撹拌しながらカードラン
を加えた後、冷却する方法が知られている。この水分散
液を加熱するとゲルを形成する。加熱によって得られる
ゲルは、その処理温度により2つの型に大別される。す
なわち、80℃以上の加熱により得られる熱不可逆性の
ゲルと、約60℃で加熱した後、冷却して得られる熱可
逆性のゲルであり、各々ハイセットゲルおよびローセッ
トゲルと呼ばれる。また加熱をしなくてもカードランを
アルカリ性水溶液に溶解し、これを静置したまま炭酸ガ
ス等で中和するか、透析膜を用いて水酸化ナトリウムを
除去することでもゲルを調製することができる。また
は、アルカリ性水溶液にカルシウムイオンやマグネシウ
ムイオンなどのカチオンを添加して解離した水酸基とカ
チオンによる架橋構造をつくらせることによってもゲル
形成させることができる。[Detailed Description of Configuration] The contact medium for the present probe is a highly hydrous gel containing curdlan as a main component. For curdlan, Vol.38, No.8,736-742 (199
1) etc., the microorganisms ( Alcaligenes faeca
Many strains of lis var .myxogenes or Agrobacterium
Rizobium) is a type of polysaccharide that is composed of only D-glucose, and 99% or more of its glucoside bonds are β-1,3 bonds. Curdlan is insoluble in water but soluble in alkaline aqueous solutions such as sodium hydroxide.
To prepare a uniform aqueous dispersion of curdlan, add water to curdlan powder and stir vigorously with a high-speed homogenizer or a cutter mixer, or stir hot water at about 55 ° C using a hand or a propeller stirrer. While adding curdlan, a method of cooling is known. A gel is formed when this aqueous dispersion is heated. Gels obtained by heating are roughly classified into two types depending on the treatment temperature. That is, a thermo-irreversible gel obtained by heating at 80 ° C. or higher and a thermo-reversible gel obtained by heating at about 60 ° C. and then cooling, which are respectively called a high set gel and a low set gel. It is also possible to prepare a gel by dissolving curdlan in an alkaline aqueous solution without heating and neutralizing it with carbon dioxide gas while still standing, or by removing sodium hydroxide using a dialysis membrane. it can. Alternatively, a gel can be formed by adding a cation such as calcium ion or magnesium ion to the alkaline aqueous solution to form a cross-linked structure with the dissociated hydroxyl group and the cation.
【0008】本発明のプローブ用接触媒体は、カードラ
ンを主成分とし含水率が80%以上のゲルであり、加熱
によるゲル化に次いで高圧処理を行うことによって得ら
れるものである。場合によっては、更に再加熱すること
により無菌化とゲル強度の向上を図ることが可能であ
る。次に、製造方法の一例を紹介する。まず前述のカー
ドラン水分散液を調製する。カードラン濃度としては、
1〜10%好ましくは2〜5%とする。この分散液を真
空下で脱気後、平板または成形用鋳型に静かに注入し、
再び真空下で充分に脱気を行う。これを加熱滅菌装置も
しくは湯浴中で60℃以上好ましくは80℃以上の温度
で、好ましくは10分間以上加熱しゲル化を行う。冷却
後、ゲルを100kg/cm2以上好ましくは1000kg/cm2
以上で高圧処理し、その後、60℃以上好ましくは80
℃以上の温度で、好ましくは10分間以上加熱を行うか
放射線照射による滅菌操作により、より強固なゲルが得
られる。この時の加熱温度は1回目以上でより長時間行
うほどゲルの強度を増すことができる。The probe contact medium of the present invention is a gel containing curdlan as a main component and having a water content of 80% or more, and is obtained by subjecting gelation by heating to high-pressure treatment. Depending on the case, it is possible to further sterilize and improve the gel strength by further reheating. Next, an example of the manufacturing method will be introduced. First, the above-mentioned curdlan aqueous dispersion is prepared. For curdlan concentration,
1 to 10%, preferably 2 to 5%. After degassing this dispersion under vacuum, gently inject it into a flat plate or molding mold,
Fully degas under vacuum again. This is heated in a heat sterilizer or a water bath at a temperature of 60 ° C. or higher, preferably 80 ° C. or higher, preferably for 10 minutes or longer to perform gelation. After cooling, the gel should be 100 kg / cm 2 or more, preferably 1000 kg / cm 2
High-pressure treatment is performed as above, and then 60 ° C. or higher, preferably 80
A stronger gel can be obtained by heating at a temperature of ℃ or more, preferably for 10 minutes or more, or by sterilization by irradiation with radiation. The heating temperature at this time is the first time or more, and the strength of the gel can be increased by performing the heating for a longer time.
【0009】最近、カードランの水分散液を高圧処理
し、次いで加熱処理することにより、ゲル強度を上げる
方法が開示されている(特開平4-158752)が、そのメカ
ニズムはいまだ明らかになっていない。穿刺・術中用に
使用する接触媒体は使用時には無菌状態でなければなら
ない。そのため接触媒体の無菌化には、病院内で簡便に
滅菌操作が行え、最も普及している加熱滅菌装置(オー
トクレーブ)が使用できることが望ましい。食品レベル
で用いられているカードラン粉末中には培地・微生物由
来の不純物が多く含まれ、粉末はわずかに褐色を帯びて
いる。穿刺・術中用に使用する接触媒体の原料として
は、当然このような不純物を含まない高度に精製された
原料を使用することが望ましい。しかしながら、このよ
うに精製されたカードラン粉末を用い、加熱ゲルを調製
すると温度の上昇(多くは100℃以上)にともないゲ
ルにひび割れを生ずるようになる。上記のようなひび割
れの原因には加熱に伴うカードラン分子の結晶化が予想
されるが、このような結晶化を抑制するには、他の物質
を添加する方法が一般的である。カードランの場合、水
に不溶性であるため、分子レベルで完全に均一な混合液
を調製することが難しい。そのためこれまで精製カード
ランゲルのひび割れを回避することは非常に困難であっ
た。Recently, a method of increasing the gel strength by subjecting an aqueous dispersion of curdlan to high pressure treatment and then heat treatment has been disclosed (Japanese Patent Laid-Open No. 4-158752), but the mechanism is still clear. Absent. Contact media used for puncture / intraoperative must be sterile when used. Therefore, for sterilization of the contact medium, it is desirable that the sterilization operation can be easily performed in a hospital and that the most popular heat sterilizer (autoclave) can be used. Curdlan powder used at the food level contains a large amount of impurities derived from culture media and microorganisms, and the powder is slightly brownish. As a raw material of the contact medium used for puncture and intraoperative use, it is naturally desirable to use a highly purified raw material containing no such impurities. However, when the curdlan powder thus purified is used to prepare a heated gel, the gel becomes cracked as the temperature rises (mostly 100 ° C. or higher). Although crystallization of curdlan molecules due to heating is expected as a cause of the above-mentioned cracks, a method of adding another substance is generally used to suppress such crystallization. In the case of curdlan, since it is insoluble in water, it is difficult to prepare a completely homogeneous mixed solution at the molecular level. Therefore, it has been very difficult to avoid cracking of the purified curdlan gel.
【0010】しかしながら、前述の加圧処理(100kg
/cm2以上、好ましくは1000〜10000kg/cm2)を
行うことにより加熱に伴うひび割れの問題を解消するこ
とが可能となった。加圧処理の方法としては100kg/c
m2以上の高圧が得られるのであればいずれの方法でもよ
いが、近年、三菱重工業より任意の温度下で、高圧処理
の行える装置が市販されている。加圧処理の手順は、特
開平4-158752にあるようにカードラン分散液を加圧処理
してから加熱ゲル化するよりも、先にひび割れの起こら
ない温度、好ましくは60〜100℃で加熱ゲル化して
から加圧処理する方が望ましく、加熱に伴う割れに対し
て高い耐性が得られる。加圧処理する際の温度は、すで
にゲル化してあるためにゲル化温度以下で行う必要はな
く、任意の温度に設定できる。However, the above pressure treatment (100 kg
/ cm 2 or more, preferably 1000 to 10,000 kg / cm 2 ) makes it possible to solve the problem of cracking due to heating. The pressure treatment method is 100 kg / c
Any method may be used as long as a high pressure of m 2 or more can be obtained, but in recent years, an apparatus capable of performing a high pressure treatment at an arbitrary temperature is commercially available from Mitsubishi Heavy Industries. The pressurizing process is carried out by heating the curdlan dispersion at a temperature at which cracking does not occur first, preferably at 60 to 100 ° C., as compared with pressurizing the curdlan dispersion liquid and then heat-gelling it as described in JP-A-4-158755. It is preferable to perform pressure treatment after gelling, and high resistance to cracking due to heating is obtained. Since the temperature at the time of pressure treatment is already gelled, it is not necessary to carry out below the gelation temperature, and it can be set to any temperature.
【0011】カードランの濃度としては、均一な分散液
の得られる濃度であればいずれでもよいが、1〜10%
好ましくは2〜5%が望ましい。1%以下では調製され
たゲルの強度が不充分であり、10%以上となると分散
液の粘度が高くなり気泡を含まない均一なゲルを得るこ
とが難しくなる。また、同ゲルを接触媒体として用いる
場合、優れた音響特性を与えるために高含水率である必
要があり、カードラン濃度として5%以下であることが
望ましい。2〜5%の濃度であってもゲルの強度は充分
であり、体表面に押し付けて変形を伴う操作にも破壊さ
れることはない。The concentration of curdlan may be any concentration as long as a uniform dispersion can be obtained, but it is 1 to 10%.
It is preferably 2 to 5%. When it is 1% or less, the strength of the prepared gel is insufficient, and when it is 10% or more, the viscosity of the dispersion becomes high, and it becomes difficult to obtain a uniform gel containing no bubbles. When the gel is used as a contact medium, it must have a high water content in order to provide excellent acoustic characteristics, and the curdlan concentration is preferably 5% or less. Even at a concentration of 2 to 5%, the strength of the gel is sufficient, and the gel will not be destroyed even if it is pressed against the body surface and undergoes deformation.
【0012】本発明のプローブ用接触媒体には、ゲルの
主成分であるカードラン以外に、他の高分子物質(例え
ば、アルギン酸、カラギナン、寒天、グルコマンナン、
でんぷん、ヒアルロン酸、スクレログルカン、シゾフィ
ラン、レンチナン、パラミロン、カロース、ラミナラ
ン、セルロース、メチルセルロース、エチルセルロー
ス、ニトロセルロース、ポリビニルアルコール)や各種
の塩類(例えば、リン酸、酢酸、乳酸、クエン酸、ホウ
酸の各ナトリウム塩もしくはカリウム塩、塩化ナトリウ
ム)、各種の糖類(例えば、グルコース、シュクロー
ス、マルトース、ガラクトース、マンノース、ラクトー
ス等)、尿素、グリセリン、シリコーンのうち1種類も
しくは2種以上の物質を配合することによっても、より
優れた特性を示すゲルが得られる。In the contact medium for a probe of the present invention, in addition to the curdlan which is the main component of the gel, other polymeric substances (eg, alginic acid, carrageenan, agar, glucomannan,
Starch, hyaluronic acid, scleroglucan, schizophyllan, lentinan, paramylon, callose, laminaran, cellulose, methyl cellulose, ethyl cellulose, nitrocellulose, polyvinyl alcohol) and various salts (eg phosphoric acid, acetic acid, lactic acid, citric acid, boric acid) Each sodium salt or potassium salt, sodium chloride), various sugars (for example, glucose, sucrose, maltose, galactose, mannose, lactose, etc.), urea, glycerin, silicone, and one or more substances are mixed. Also by doing so, a gel showing more excellent properties can be obtained.
【0013】このようにして調製されるゲルは、適度な
柔軟性を有すると共に、成形が極めて容易であり、一定
の形状を持つプローブと接触媒体との接続を考えた場
合、非常に有利である。このようにして調製されたゲル
は、全て良好な音響特性を示した。すなわち、音速は水
の場合に近い 1490 〜 1543 m/s 、減衰は 0.05 〜 0.2
3 dB/MHz・cmであり、これまで知られているゲルのうち
で最も低い減衰率を示した。また、同ゲルの機械的強度
を測定したところ、破壊強度 5.91x102 〜 4.64x103g/c
m2、ヤング率 2.16x106 〜 7.38x106 dyn/cm2 を示し、
プローブ用接触媒体として使用するのに充分な強度を持
つことも明かであった。The gel thus prepared has appropriate flexibility and is extremely easy to mold, and is extremely advantageous in consideration of connection between a probe having a certain shape and a contact medium. . The gels thus prepared all showed good acoustic properties. That is, the speed of sound is close to that of water 1490 to 1543 m / s, and the attenuation is 0.05 to 0.2.
It was 3 dB / MHz · cm, and showed the lowest attenuation rate among the gels known so far. In addition, the mechanical strength of the gel was measured, and it was found that the fracture strength was 5.91x10 2 to 4.64x10 3 g / c.
m 2 , Young's modulus 2.16x10 6 to 7.38x10 6 dyn / cm 2 ,
It was also clear that it had sufficient strength to be used as a contact medium for probes.
【0014】[0014]
【実施例】以下、実施例により本発明を更に具体的に説
明する。 実施例1 カードラン(武田薬品工業(株))3.5 重量部に 96.5
重量部の水を加え、高速ホモジナイザーで10分間撹拌
した。上記カードラン水分散液を真空下で充分に脱気
後、型に注入し100℃、10分間の加熱によりゲル化
を行った。冷却し型から取り出した後、ヒートシールパ
ックに充填し高圧処理装置により21℃、3000kg/c
m2、10分間の処理を行った。その後、加熱滅菌器で1
21℃、20分間の加熱を行い、この操作により完全な
ゲル化と滅菌が同時に可能であった。上記のように調製
したゲルについて音響特性を測定した結果、音速150
2m/s、減衰0.14dB/MHz・cmとの値を得た。また、
レオメーター(不動工業(株)製;NRM-2010J-CW)で物
性を測定したところ、破壊強度 2.97x103 g/cm2 、ヤン
グ率 5.19x106 dyn/cm2 を示した。次に、上記接触媒体
を超音波診断装置のプローブと皮膚の間に置き画像診断
を行ったところ、ゲルを介在せしめない場合に比較し明
かに鮮明な画像が得られた。The present invention will be described in more detail with reference to the following examples. Example 1 96.5 parts by weight of curdlan (Takeda Pharmaceutical Co., Ltd.)
By weight of water was added, and the mixture was stirred with a high speed homogenizer for 10 minutes. The above curdlan aqueous dispersion was thoroughly degassed under vacuum, poured into a mold, and gelled by heating at 100 ° C. for 10 minutes. After cooling and taking out from the mold, it is filled in a heat-sealed pack and heated at 21 ° C and 3000 kg / c by a high-pressure processing device.
A treatment of m 2 for 10 minutes was performed. Then, 1 with a heat sterilizer
By performing heating at 21 ° C. for 20 minutes, complete gelation and sterilization were possible at the same time by this operation. As a result of measuring the acoustic characteristics of the gel prepared as described above, a sound velocity of 150
Values of 2 m / s and 0.14 dB / MHz · cm attenuation were obtained. Also,
When the physical properties were measured with a rheometer (NRM-2010J-CW manufactured by Fudo Kogyo Co., Ltd.), the breaking strength was 2.97x10 3 g / cm 2 , and the Young's modulus was 5.19x10 6 dyn / cm 2 . Next, when the above contact medium was placed between the probe of the ultrasonic diagnostic apparatus and the skin for image diagnosis, a clear and clear image was obtained as compared with the case where no gel was interposed.
【0015】比較例1 高圧処理を除き、実施例1と全く同様の操作でカードラ
ンゲルを得た。同ゲルは121℃、20分間の加熱によ
ってひび割れを生じ、超音波診断装置のプローブ用接触
媒体としては不適切であった。これに対し、実施例1の
高圧処理ゲルは121℃、20分間の処理を繰り返して
もひび割れを全く生ずることがなく、明かに耐熱性が向
上していた。Comparative Example 1 A curdlan gel was obtained by the same procedure as in Example 1 except for the high pressure treatment. The gel was cracked by heating at 121 ° C. for 20 minutes and was unsuitable as a contact medium for a probe of an ultrasonic diagnostic apparatus. On the other hand, the high-pressure treated gel of Example 1 had no cracking even after repeated treatment at 121 ° C. for 20 minutes, and the heat resistance was clearly improved.
【0016】比較例2(特開平4-158752の記載による) 実施例1に基づき、3.5 %カードラン分散液を調製し脱
気を行った。この分散液をヒートシールパックに充填
し、高圧処理装置により21℃、3000kg/cm2、10
分間の処理を行った。その後、この処理済み分散液を型
に静注し、100℃, 10分間の加熱によりゲル化を行
い、冷却後、型から取り外した。続いて121℃, 20
分間の加熱により滅菌を行ったところ、多数のひび割れ
を生じ、超音波診断装置のプローブ用接触媒体としては
不適切であった。Comparative Example 2 (as described in JP-A-4-158755) Based on Example 1, a 3.5% curdlan dispersion was prepared and deaerated. This dispersion was filled in a heat-sealed pack, which was then heated at 21 ° C. and 3000 kg / cm 2 , 10 kg.
A treatment for 1 minute was performed. Then, this treated dispersion liquid was intravenously injected into a mold, heated at 100 ° C. for 10 minutes for gelation, cooled, and then removed from the mold. Then 121 ℃, 20
When sterilized by heating for a minute, many cracks were formed, which was unsuitable as a contact medium for a probe of an ultrasonic diagnostic apparatus.
【0017】実施例2 上記実施例の水の代りに、等張の塩化ナトリウム水溶液
を用いさらに、カードラン濃度を2から5%に調整して
プローブ用接触媒体を調製した。この様に塩を添加する
ことにより、水の場合に比較して保存中のゲルの劣化防
止が可能となった。また、塩の添加による音響特性の低
下は全く認められず(表1)、上記プローブ用接触媒体
を使用することにより、鮮明な診断画像が得られた。Example 2 A contact medium for a probe was prepared by using an isotonic sodium chloride aqueous solution instead of the water in the above example and further adjusting the curdlan concentration to 2 to 5%. By adding salt in this way, it became possible to prevent the deterioration of the gel during storage as compared with the case of water. Further, no deterioration in acoustic characteristics due to the addition of salt was observed (Table 1), and a clear diagnostic image was obtained by using the contact medium for a probe.
【0018】 〔表1〕カードランゲルの音響特性に及ぼす塩の影響 ━━━━━━━━━━━━━━━━━━━━━━━━━ 調製液 カードラン 音速 減衰 濃 度 m/s dB/MHz・cm ───────────────────────── 水 2 % 1495 0.07 3 % 1498 0.09 4 % 1508 0.13 5 % 1507 0.16 ───────────────────────── 生理的食塩水 2 % 1510 0.08 3 % 1515 0.09 4 % 1519 0.14 5 % 1522 0.17 ━━━━━━━━━━━━━━━━━━━━━━━━━[Table 1] Effect of salt on acoustic characteristics of curdlan gel ━━━━━━━━━━━━━━━━━━━━━━━━━ Preparation liquid curdlan Sound velocity attenuation Concentration m / s dB / MHz ・ cm ───────────────────────── Water 2% 1495 0.07 3% 1498 0.09 4% 1508 0.13 5% 1507 0.16 ───────────────────────── Physiological saline 2% 1510 0.08 3% 1515 0.09 4% 1519 0.14 5% 1522 0.17 ━━━━━ ━━━━━━━━━━━━━━━━━━━━
【0019】実施例3 カードラン7重量部、アルギン酸 0.3重量部に 92.7 重
量部の水を加え高速ホモジナイザーで、13000回転
/分、5分間撹拌した。これを真空下で脱気した後、型
に注入し100℃、10分間の加熱によりゲル化を行っ
た。冷却し型から取りはずした後、10%塩化カルシウ
ム溶液に浸しアルギン酸のゲル化を行った。24時間後
にゲルを取り出して水洗後、ヒートシールパックに充填
し高圧処理装置により21℃、10分間で5000kg/c
m2の処理を行った。その後、加熱滅菌器で121℃、2
0分間の加熱を行い完全なゲル化と滅菌を同時に行っ
た。得られたプローブ用接触媒体を用いて超音波診断を
行ったところ、接触媒体を用いない場合に比較し、明か
に鮮明な画像が得られた。Example 3 7 parts by weight of curdlan and 0.3 parts by weight of alginic acid were mixed with 92.7 parts by weight of water, and the mixture was stirred with a high-speed homogenizer at 13000 rpm for 5 minutes. This was degassed under vacuum, then poured into a mold and heated at 100 ° C. for 10 minutes to cause gelation. After cooling and removing from the mold, the gel was dipped in a 10% calcium chloride solution to gel alginic acid. After 24 hours, take out the gel, wash it with water, fill it in a heat-seal pack, and use a high-pressure processor at 21 ° C for 10 minutes to 5000 kg / c.
m 2 was processed. Then, heat sterilizer at 121 ℃, 2
After heating for 0 minutes, complete gelation and sterilization were performed at the same time. When ultrasonic diagnosis was performed using the obtained contact medium for a probe, a clear and clear image was obtained as compared with the case where the contact medium was not used.
【0020】[0020]
【発明の効果】本発明の超音波診断装置プローブ用接触
媒体は高含水率のゲルからなり、極めて優れた超音波特
性・機械的強度を持つものである。しかも、天然多糖類
を原料としているために安全性も高く、加えて安価に大
量に供給が可能である。また、通常の加圧滅菌装置が使
用でき無菌化も容易である。また、本発明のプローブ用
接触媒体は、適当な接続部品を用いて超音波診断装置の
プローブに直接固定することが可能であり、その使用性
は従来に比較してはるかに向上するものと考えられる。The contact medium for the probe of the ultrasonic diagnostic apparatus of the present invention is composed of a gel having a high water content and has extremely excellent ultrasonic characteristics and mechanical strength. Moreover, since the natural polysaccharide is used as a raw material, it is highly safe, and in addition, it can be inexpensively supplied in large quantities. In addition, an ordinary autoclave can be used and sterilization is easy. Further, the probe contact medium of the present invention can be directly fixed to the probe of the ultrasonic diagnostic apparatus by using an appropriate connecting component, and its usability is considered to be much improved as compared with the conventional one. To be
Claims (3)
理して得られる超音波診断装置のプローブ用接触媒体。1. A contact medium for a probe of an ultrasonic diagnostic apparatus, which is obtained by high-pressure treatment of a gel containing curdlan as a main component.
音波伝播の音速 1480m/s〜 1550m/s、減衰率 0.3dB/MHz
・cm以下である、請求項1記載の超音波診断装置のプロ
ーブ用接触媒体。2. The curdlan concentration is 1 to 10%, the sound velocity of ultrasonic wave propagation is 1480 m / s to 1550 m / s, and the attenuation rate is 0.3 dB / MHz.
The contact medium for a probe of the ultrasonic diagnostic apparatus according to claim 1, which has a size of cm or less.
請求項1又は2記載の超音波診断装置プローブ用接触媒
体。3. The contact medium for an ultrasonic diagnostic apparatus probe according to claim 1, wherein the high-pressure treatment condition is 100 kg / cm 2 or more.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1804793A JP2944350B2 (en) | 1993-01-08 | 1993-01-08 | Contact medium for probe of ultrasonic diagnostic equipment |
| DE69330308T DE69330308T2 (en) | 1992-12-02 | 1993-12-02 | COUPLING AGENT FOR AN ULTRASONIC PROBE |
| PCT/JP1993/001759 WO1994012105A1 (en) | 1992-12-02 | 1993-12-02 | Contact medium for probe of ultrasonic diagnostic apparatus |
| EP94901030A EP0628284B1 (en) | 1992-12-02 | 1993-12-02 | Contact medium for probe of ultrasonic diagnostic apparatus |
| US08/284,420 US5579769A (en) | 1992-12-02 | 1993-12-02 | Coupling medium for probe of ultrasonograph |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1804793A JP2944350B2 (en) | 1993-01-08 | 1993-01-08 | Contact medium for probe of ultrasonic diagnostic equipment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH07124154A true JPH07124154A (en) | 1995-05-16 |
| JP2944350B2 JP2944350B2 (en) | 1999-09-06 |
Family
ID=11960785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1804793A Expired - Fee Related JP2944350B2 (en) | 1992-12-02 | 1993-01-08 | Contact medium for probe of ultrasonic diagnostic equipment |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2944350B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0893452A3 (en) * | 1997-07-25 | 1999-02-03 | Shiseido Company Limited | Protein removed beta-1,3 glucan and coupling medium for probe of ultrasonograph containing same |
| WO2001016590A3 (en) * | 1999-08-30 | 2001-06-21 | Fraunhofer Ges Forschung | Coupling medium for transversal ultrasonic waves |
| JP2012176197A (en) * | 2011-02-28 | 2012-09-13 | Nagasaki Univ | Film echo gel and ultrasonic sensor unit |
-
1993
- 1993-01-08 JP JP1804793A patent/JP2944350B2/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0893452A3 (en) * | 1997-07-25 | 1999-02-03 | Shiseido Company Limited | Protein removed beta-1,3 glucan and coupling medium for probe of ultrasonograph containing same |
| WO2001016590A3 (en) * | 1999-08-30 | 2001-06-21 | Fraunhofer Ges Forschung | Coupling medium for transversal ultrasonic waves |
| US6899677B1 (en) | 1999-08-30 | 2005-05-31 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Coupling medium for transversal ultrasonic waves |
| JP2012176197A (en) * | 2011-02-28 | 2012-09-13 | Nagasaki Univ | Film echo gel and ultrasonic sensor unit |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2944350B2 (en) | 1999-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0628284B1 (en) | Contact medium for probe of ultrasonic diagnostic apparatus | |
| US7736619B2 (en) | Hydrogel compositions and manufacturing process for ultrasound couplants | |
| US20050074407A1 (en) | PVP and PVA as in vivo biocompatible acoustic coupling medium | |
| US20010039380A1 (en) | In vivo biocompatible acoustic coupling media | |
| JPH08269102A (en) | Endotoxin-free beta-1,3-glucan, its production and gel material for medical purpose | |
| CN104086788A (en) | Modified sodium hyaluronate gel for injection | |
| WO2020162764A1 (en) | Surgical hydrogel | |
| JP2944350B2 (en) | Contact medium for probe of ultrasonic diagnostic equipment | |
| JP2944393B2 (en) | Contact medium for probe of ultrasonic diagnostic equipment | |
| CN106620734B (en) | A kind of sterile medical supersonic coupled patch and preparation method thereof | |
| JP3267410B2 (en) | Contact medium for probe of ultrasonic diagnostic equipment | |
| CN111674113B (en) | A kind of preparation method of large-scale ductile phantom | |
| CN107510851B (en) | A kind of medical ultrasonic coupling pad and preparation method thereof | |
| JP4875804B2 (en) | Hemostatic material | |
| JP3212773B2 (en) | Contact medium for probe of ultrasonic diagnostic equipment | |
| CN118743769A (en) | A sterile medical ultrasonic coupling agent and its production process | |
| JP3183583B2 (en) | Contact medium for probe of ultrasonic diagnostic equipment | |
| US20120197164A1 (en) | Ultrasound couplant | |
| JP3167649B2 (en) | Β-1,3 glucan from which protein has been removed and a contact medium for a probe of an ultrasonic diagnostic apparatus comprising a gel containing the same as a main component | |
| JPH05245138A (en) | Production of polyvinyl alcohol gel for ultrasonic medium | |
| CN1990048A (en) | Ultrasonic therapy couplant, its preparing process and packing apparatus | |
| JP2002155103A (en) | ENDOTOXIN-FREE beta-1,3-GLUCAN, METHOD FOR THE SAME AND MEDICAL GEL MATERIAL | |
| CN115590985B (en) | Sterile medical ultrasonic coupling agent and preparation method thereof | |
| CN118161648B (en) | Yeast β-glucan and collagen composite hemostatic sponge and its preparation and application | |
| CN118252956A (en) | Sterile medical ultrasonic coupling agent and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19990611 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |